# Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients

> **NCT06414044** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Florence** · enrollment: 500 (actual)

## Conditions studied

- Migraine
- Migraine With Aura
- Migraine Without Aura
- Chronic Migraine

## Interventions

- **DRUG:** Atogepant 60 mg

## Key facts

- **NCT ID:** NCT06414044
- **Lead sponsor:** University of Florence
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-09
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-04
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2026-01-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414044, "Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06414044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*